Beijing Science Sun Pharmaceutical Co., Ltd. (SHE:300485)
China flag China · Delayed Price · Currency is CNY
10.30
+0.68 (7.07%)
Aug 20, 2026, 3:04 PM CST

SHE:300485 Cash Flow Statement

Millions CNY. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Net Income
-20.7414.57-68.85102.92204.73402.27
Depreciation & Amortization
47.2547.2547.2548.7447.655.68
Other Amortization
0.080.08--0.031.04
Loss (Gain) From Sale of Assets
-0.11-0.11--0-6.65-6.57
Asset Writedown & Restructuring Costs
11.4911.490.05-0.04-1.06
Loss (Gain) From Sale of Investments
-37.27-37.27108.13-160.07-212.12-318.44
Provision & Write-off of Bad Debts
-0.89-0.89-1.17-1.59-0.61-
Other Operating Activities
35.37-0.2-5.52-6.57-1.73-7.14
Change in Accounts Receivable
-12.4-12.414.7139.171.1734.48
Change in Inventory
8.48.422.36-17.9733.9636.52
Change in Accounts Payable
-5.49-5.4937.98-7.32-8.71-38.42
Change in Other Net Operating Assets
2.12.10.39-3.45-
Operating Cash Flow
27.3527.08135.9721.21110.43183.3
Operating Cash Flow Growth
-73.84%-80.08%541.05%-80.79%-39.75%-30.50%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Capital Expenditures
-99.43-100.28-101.13-52.91-43.28-45.91
Sale of Property, Plant & Equipment
0.020.18-0.0310.9115.25
Cash Acquisitions
-----4.43-
Investment in Securities
72.7112.08-99.45-48.9929.27-674.77
Other Investing Activities
43.5642.2925.2215.6139.9242.96
Investing Cash Flow
16.86-45.73-175.36-86.2632.39-662.47

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Short-Term Debt Issued
-19.99----
Total Debt Issued
19.9919.99----
Net Debt Issued (Repaid)
19.9919.99----
Issuance of Common Stock
--4.7---
Common Dividends Paid
-0.5-0.25-10.59-41.4-80.88-31.31
Other Financing Activities
----0.72-
Financing Cash Flow
19.4919.74-5.89-41.4-80.16-31.31

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Foreign Exchange Rate Adjustments
-0.89-0.530.370.42-0.51
Net Cash Flow
62.80.56-44.9-106.0564.67-510.99

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Free Cash Flow
-72.09-73.234.85-31.767.15137.38
Free Cash Flow Growth
-----51.12%-5.83%
Free Cash Flow Margin
-17.90%-18.09%8.37%-6.65%9.14%13.07%
Free Cash Flow Per Share
-0.15-0.150.07-0.070.140.29
Levered Free Cash Flow
-62.09-59.0930.21-33.1544.6392.42
Unlevered Free Cash Flow
-61.76-58.8130.21-33.1544.6392.42

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Jan '23 Jan '22
Cash Income Tax Paid
57.4258.2521.7123.5749.2286.67
Change in Working Capital
-7.83-7.8356.0937.7979.1457.5